Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
Times cited: 13
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
Breast Cancer Research and Treatment.
Times cited: 46